Remove Cosmetics Remove Generic Pharmaceutical Remove HR Remove Protein
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. billion the drug generated in 2021. The monoclonal antibody targets CD20, a protein found on the surface of B lymphocytes (B cells).

Sales 98